Are you Dr. Amiri Kordestani?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 18 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
110 Irving St NW
Washington, DC 20010Phone+1 202-877-7227Fax+1 202-444-5104
Summary
- Dr. Laleh Amiri Kordestani, MD is an oncologist in Washington, District of Columbia. She is currently licensed to practice medicine in District of Columbia and Maryland. She is affiliated with MedStar Georgetown University Hospital.
Education & Training
Tehran University of Medical Sciences School of MedicineClass of 2003
Certifications & Licensure
DC State Medical License 2013 - 2024
MD State Medical License 2009 - 2016
Publications & Presentations
PubMed
- Most Common Symptomatic Adverse Reactions of Cancer Treatments From US Drug Labels (2015-2021) to Inform Selection of Patient-Reported Outcomes.Erica G Horodniceanu, Tejaswi Datla, Meena N Murugappan, Bindu Kanapuru, Laleh Amiri-Kordestani
Value in Health. 2025-01-01 - FDA Approval Summary: Capecitabine Labeling Update under Project Renewal.Sundeep Agrawal, Clara Lee, William F Pierce, Elizabeth Everhart, Adriene King-Ducre
Clinical Cancer Research. 2024-12-16 - 1 citationsUS Food and Drug Administration Approval Summary: Capivasertib With Fulvestrant for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Locall...Asma Dilawari, James Buturla, Christy Osgood, Xin Gao, Wei Chen
Journal of Clinical Oncology. 2024-12-01
Press Mentions
Special Session Explores Considerations Behind Breast Cancer Drug Approvals, TrialsDecember 15th, 2024
